Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7274
    +0.0011 (+0.15%)
     

  • CRUDE OIL

    83.34
    +0.61 (+0.74%)
     

  • Bitcoin CAD

    88,146.45
    +845.78 (+0.97%)
     

  • CMC Crypto 200

    1,381.07
    +68.45 (+5.41%)
     

  • GOLD FUTURES

    2,402.90
    +4.90 (+0.20%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     
MARKETS LIVE BLOG:

S&P 500 SLIPS BELOW 5,000; NASDAQ SINKS ON NETFLIX DRAG

Fed's Goolsbee says 'It makes sense to wait' before cutting rates

Theratechnologies to Announce First Quarter 2023 Financial Results and Provide Business Update

Theratechnologies
Updated ·2 min read
Theratechnologies
Theratechnologies

MONTREAL, April 03, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will report financial results for its first quarter 2023 ended February 28, on Wednesday, April 12, 2023.  

The conference call will be held on Wednesday, April 12, 2023, hosted by Mr. Paul Lévesque, President and Chief Executive Officer, and begin at 8:30 a.m. ET. Joining Mr. Lévesque on the call will be other members of the management team, including Chief Financial Officer Mr. Philippe Dubuc, Chief Medical Officer Dr. Christian Marsolais, and Global Commercial Officer Mr. John Leasure, who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least ten minutes in advance to secure access.

ADVERTISEMENT

Conference call dial-in and replay information is below:

CONFERENCE CALL INFORMATION

Conference Call Date:

April 12, 2023

Conference Call Time:

8:30 AM ET

North America Dial-in:

1-877-513-4119

International Dial-in:

1-412-902-6615

Access Code:

4314981

CONFERENCE CALL REPLAY

North America Dial-in:

1-877-344-7529

International Dial-in:

1-412-317-0088

Replay Access Code:

8857934

Replay End Date

April 19, 2023

The live conference call will be accessible via webcast at:
https://edge.media-server.com/mmc/p/nt9j2fgq

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

Investor Inquiries:
Elif McDonald
Senior Director, Investor Relations
ir@theratech.com
1-438-315-8563

Media Inquiries:
Julie Schneiderman
Senior Director, Communications and Corporate Affaires
communications@theratech.com
1 514 336-7800